PTX 3.61% 4.3¢ prescient therapeutics limited

Ann: Trading Halt, page-14

  1. 601 Posts.
    lightbulb Created with Sketch. 839
    Possibly Swan, but a cap raise was always on the cards after CAR-T platform acquisition and development.
    Cap raises are a necessary evil of 'successful' microcap biotechs.
    Institutional placement would be the best outcome.
    These players will need to know (and believe in) PTX's strategic plan.
    If the 'Friendly Dwarf' is involved no doubt we will get a heads up on the value $ raise and at what price.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.3¢
Change
0.002(3.61%)
Mkt cap ! $34.62M
Open High Low Value Volume
4.2¢ 4.3¢ 4.1¢ $14.70K 349.5K

Buyers (Bids)

No. Vol. Price($)
1 15222 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 20003 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.